IRVING, Texas — McKesson Corp. is going from strength to strength as it realigns the team that provides support to pharmacy operators across the country. In the wake of Chris Dimos’ retirement as president of retail solutions, the drug wholesaler has named Nimesh Jhaveri president of community pharmacy, and Eyad Farah president of Health Mart
On the verge of his retirement from McKesson Corp., Chris Dimos, president of retail solutions, talks about the company’s evolution, how to unlock the full potential of community pharmacy, and his plans for the future.
SAN FRANCISCO — McKesson Corp. has promoted Chris Dimos to president of retail solutions for McKesson U.S. Pharmaceutical and Specialty Health. With the move, Dimos will now oversee the Health Mart pharmacy network, taking over from Steve Courtman, who left the company to join health insurer Cigna as senior vice president of Cigna Pharmacy. In
SAN FRANCISCO — McKesson Corp. has been given the green light from the Competition Bureau of Canada to finalize its $2.2 billion acquisition of drug chain Rexall Health. McKesson said Wednesday that under the consent agreement it signed with the bureau, it must sell a total of 26 Rexall drug stores in Alberta, British Columbia,
BENTONVILLE, Ark. — Walmart and McKesson Corp. have expanded their long-term pharmaceutical distribution pact, including a new sourcing agreement for generic drugs. McKesson and Walmart said Monday that the expanded relationship is “a natural next step.” The companies will collaborate on sourcing generics for their U.S. operations, a move that they said will add scale
TORONTO — McKesson Corp. announced on March 2 that it would strengthen its position in Canada’s pharmaceutical supply chain by acquiring drug store operator Rexall Health from Katz Group for $3 billion (Canadian). Rexall Health operates 470 Rexall/Rexall Pharma Plus pharmacies in six provinces and one territory. McKesson already owns drug stores in Canada and
TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $1.9 billion ($3 billion Canadian). McKesson and Katz Group said Wednesday that the deal will strengthen McKesson’s position in Canada’s pharmaceutical supply chain and is described as a natural step for two companies that have worked together for